LifeSci Communications Fierce Pharma Asia—Takeda's Anima mRNA translation pact, China digital health incubator; Daiichi's COVID-19 vaccine
Por um escritor misterioso
Descrição
Takeda penned a potentially billion-dollar deal with Anima Biotech to work on mRNA translation modulators for neurological diseases. The Japanese pharma als
LifeSci Communications Fierce Pharma Asia—Takeda's Anima mRNA translation pact, China digital health incubator; Daiichi's COVID-19 vaccine
BioSpectrum Asia Jan 2023 - Flip eBook Pages 1-50
Anima Biotech - mRNA Lightning Platform
Press Releases - Media - Daiichi Sankyo
Press Releases - Media - Daiichi Sankyo
Anima Biotech - mRNA Lightning Platform
Press Releases - Media - Daiichi Sankyo
Sponsor Detail Template – Chinese American Biopharmaceutical Society
Knowledge Library -, Growth Advisory
World's First Inhalable COVID-19 Vaccine Approved in China - COVID-19 - mobile.
Anima Biotech - Company info. interviews, news
Sponsor Detail Template – Chinese American Biopharmaceutical Society
de
por adulto (o preço varia de acordo com o tamanho do grupo)